Submission Details
| 510(k) Number | K202267 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 11, 2020 |
| Decision Date | December 31, 2020 |
| Days to Decision | 142 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
K202267 is an FDA 510(k) clearance for the Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles, a Source, Brachytherapy, Radionuclide (Class II — Special Controls, product code KXK), submitted by Isoray Medical, Inc. (Richland, US). The FDA issued a Cleared decision on December 31, 2020, 142 days after receiving the submission on August 11, 2020. This device falls under the Radiology review panel. Regulated under 21 CFR 892.5730.
| 510(k) Number | K202267 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 11, 2020 |
| Decision Date | December 31, 2020 |
| Days to Decision | 142 days |
| Submission Type | Traditional |
| Review Panel | Radiology (RA) |
| Summary | Summary PDF |
| Product Code | KXK — Source, Brachytherapy, Radionuclide |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.5730 |